Niclosamide piperazine salt
Properties
- Molecular formula
- C17H18Cl2N4O4
- Molar mass
- 413.26 g/mol
- Exact mass
- 412.0705 Da
- logP
- 3.42Crippen estimate
- Polar surface area
- 120.0 Ų
- H-bond donors / acceptors
- 4 / 6
- Rotatable bonds
- 3
Hazards
No GHS classification is on file for this compound. That is not evidence that it is harmless.
Identifiers
CAS number
34892-17-6SMILES
C1CNCCN1.O=[N+]([O-])c1ccc(N=C(O)c2cc(Cl)ccc2O)c(Cl)c1InChIKey
IAIUNINVFIUGNZ-UHFFFAOYSA-NInChI
InChI=1S/C13H8Cl2N2O4.C4H10N2/c14-7-1-4-12(18)9(5-7)13(19)16-11-3-2-8(17(20)21)6-10(11)15;1-2-6-4-3-5-1/h1-6,18H,(H,16,19);5-6H,1-4H2Weigh it out
Type any one amount. The others follow from the molar mass.
Names and synonyms
3 names
- Benzamide, 5-chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxy-, compd. with piperazine (1:?)
- Benzamide, 5-chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxy-, compd. with piperazine
- Piperazine, compd. with 5-chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide
Work with Niclosamide piperazine salt
Stereoisomers, salts and isotopologues
The same compound in another form: other stereochemistry, a salt or hydrate, the free acid or base, or an isotope-labelled version.
Arpezine142-63-2Hydrate
Niclosamide50-65-7Free acid
Piperazine110-85-0Free base
Piperazine citrate144-29-6Salt
Piperazine adipate142-88-1Salt
Niclosamide ethanolamine salt1420-04-8Salt
Ogen7280-37-7Salt
Piperazine hydrochloride142-64-3Salt
Piperazine phosphate14538-56-8Salt
Piperazine, phosphate (1:?)1951-97-9Salt
Piperazine, phosphate, hydrate (1:1:1)18534-18-4Salt
Piperazine, 2-hydroxy-1,2,3-propanetricarboxylate (3:2), hydrate41372-10-5Salt
Similar compounds
Nitrofungin619-08-949 % similar
2-Chloro-5-nitrobenzanilide22978-25-245 % similar
Pigment red 42814-77-945 % similar
Aklomide3011-89-044 % similar
3-Hydroxy-3'-nitro-2-naphthanilide135-65-944 % similar
2-Chloro-5-nitrophenol619-10-344 % similar
5-Chlorosalicylanilide4638-48-643 % similar
5-Nitrosalicylic acid96-97-943 % similar
Tanimoto similarity of circular fingerprints over the whole catalogue.